Interested in specific information?

Filter what you see here

aGvHD

Quick poll

Abatacept granted breakthrough therapy designation for the prevention of…

Abatacept granted breakthrough therapy designation for the prevention of acute GvHD

Closes Dec 6, 2019

aGvHD,   cGvHD

Quick poll

Monthly Theme | Prognostic factors for GvHD

Closes Dec 5, 2019

aGvHD,   cGvHD

Quick poll

Non-myeloablative conditioning prior to allogeneic stem cell…

Closes Nov 26, 2019

aGvHD,   cGvHD

Quick poll

The role of butyrogenic bacteria after the onset of acute…

The role of butyrogenic bacteria after the onset of acute graft-versus-host disease (aGvHD)

Closes Nov 13, 2019

cGvHD,   aGvHD

Quick poll

Treosulfan or busulfan plus fludarabine as conditioning treatment before…

Closes Nov 12, 2019

aGvHD,   cGvHD

Quick poll

Impact of donor type on outcomes of allogeneic transplant

Closes Nov 1, 2019

aGvHD,   cGvHD

Quick poll

Effect of conditioning regimen intensity after haploidentical…

Effect of conditioning regimen intensity after haploidentical transplantation

Closes Oct 30, 2019

aGvHD

Quick poll

CD3/CD7-IT receives Fast Track designation from the FDA for the treatment…

Closes Oct 22, 2019

aGvHD,   cGvHD

Quick poll

Post-transplant outcomes of patients with therapy-related AML following…

Closes Oct 17, 2019

aGvHD,   cGvHD

Quick poll

HLA-DPB1 mismatch models after unrelated donor stem cell transplantation

HLA-DPB1 mismatch models after unrelated donor stem cell transplantation

Closes Oct 16, 2019

GvHD Prophylaxis,   cGvHD

Quick poll

MRD-negativity after tandem autologous-allogeneic HSCT with bortezomib…

Closes Oct 14, 2019

GvHD Prophylaxis

Quick poll

GvHD prophylaxis in mismatched, unrelated allogeneic stem cell transplant:…

Closes Oct 9, 2019

GvHD Prophylaxis

Quick poll

Monthly theme | GvHD prophylaxis

Monthly theme | GvHD prophylaxis

Closes Oct 8, 2019

aGvHD

Quick poll

Cannabidiol (CBD) receives Notice of Allowance for EU patent for the…

Closes Oct 3, 2019

aGvHD

Quick poll

NLRP6 aggravates graft-versus-host disease (GvHD) regardless of…

Closes Sep 30, 2019
A global online platform providing latest treatment options and medical information in graft versus host disease

Latest Medical Information

Expert Opinions

Congress coverage

Upcoming congress

61st ASH Annual Meeting & Exposition

December 7-10, 2019 | Orange County Convention Center (OCCC), Orlando, FL

The GvHD Hub will be attending the 61st ASH Annual Meeting & Exposition in Orange County Convention Center (OCCC), Orlando, FL We will be presenting live coverage via our social media channels, interviewing world-leading experts and providing summaries of key sessions. Stay tuned to follow our first-hand coverage.

Use the following hashtags on Twitter to join the conversation: #GvHD #gvhdsm

Event Website

Connect with us

Our sister hubs

Visit our other community physician education hubs in haematology and oncology